# EDGAR Filing Document

**Accession Number:** 0001361896
**File Stem:** 0001731122-25-001419
**Filing Date:** 2025-10
**Character Count:** 7641
**Document Hash:** 7c78b5a7f428f3130a59b8464e9bb6a8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001731122-25-001419.hdr.sgml**: 20251021

**ACCESSION NUMBER**: 0001731122-25-001419

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251021

**DATE AS OF CHANGE**: 20251021

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SPLASH BEVERAGE GROUP, INC.
- **CENTRAL INDEX KEY:** 0001553788
- **STANDARD INDUSTRIAL CLASSIFICATION:** BEVERAGES [2080]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 341720075
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-91055
- **FILM NUMBER:** 251407488

**BUSINESS ADDRESS:**
- **STREET 1:** 1314 E LAS OLAS BLVD, SUITE 221
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33301
- **BUSINESS PHONE:** 954.745.5815

**MAIL ADDRESS:**
- **STREET 1:** 1314 E LAS OLAS BLVD, SUITE 221
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33301

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Canfield Medical Supply, Inc.
- **DATE OF NAME CHANGE:** 20120709
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Yorke Justin W
- **CENTRAL INDEX KEY:** 0001361896

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**MAIL ADDRESS:**
- **STREET 1:** C/O JMG EXPLORATION
- **STREET 2:** 180 SOUTH LAKE AVENUE
- **CITY:** PASADENA
- **STATE:** CA
- **ZIP:** 91101

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**SPLASH BEVERAGE GROUP, INC.**

*(Name of Issuer)*

**Common Stock, $0.001 par value**

*(Title of Class of Securities)*

**84862C302**

*(CUSIP Number)*

**Constantine Christakis, Esq.**<br>3001 PGA Blvd.<br>Suite 305<br>Palm Beach Gardens FL 33410<br>561-686-3307

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**07/31/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **84862C302** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Yorke Justin W** | Name of reporting person<br>**Yorke Justin W** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**907979.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**907979.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**907979.00** | Aggregate amount beneficially owned by each reporting person<br>**907979.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**28.6%** | Percent of class represented by amount in Row (11)<br>**28.6%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, $0.001 par value

**(b) Name of Issuer:**
SPLASH BEVERAGE GROUP, INC.

**(c) Address of Issuer's Principal Executive Offices:**
1314 E Las Olas Blvd., Suite 221, Ft. Lauderdale, FL, 33301

This Schedule 13D relates to the common stock, par value $0.001 per share, of Splash Beverage Group, Inc., a Nevada corporation (the "Issuer"). The Issuer's principal executive offices are located at 1314 E Las Olas Blvd., Suite 221, Ft. Lauderdale, Florida 33301. The shares beneficially owned include shares of common stock issuable upon exercise of warrants issued to the Issuer's officers, directors and certain employees as of July 31, 2025. All of the warrants are fully vested with one exception. The warrants held by the Reporting Person are fully vested. Because of the Rules of the Securities and Exchange Commission, in calculating beneficial ownership, the common stock which could be exercised or converted in 60 days is deemed to be beneficially owned by a person. However, the underlying common stock issuable to other persons is not included in a reporting person's calculations. In this Schedule 13D and others being filed at about the same time, a number of people will each report beneficial ownership over 20%; if they were all aggregated, the beneficial ownership percentage would be reduced.  Further if other derivative securities were included and beneficial ownership limitations of certain third parties were disregarded, the percentages reflected in this Schedule 13D would be reduced even further.

**Item 4. Purpose of Transaction**

The Reporting Person is a director of the Issuer. He acquired all of his securities with the purpose of exercising control.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The Reporting Person beneficially owns (i) 6,242 shares of the Issuer's common stock, (ii) 137,153 shares of the Issuer's common stock indirectly through Richland Fund, LLC, an entity the Reporting Person controls, (iii) 8,333 shares of common stock issuable upon exercise of warrants to purchase shares of the Issuer's common stock with an exercise price of $30.00 per share, (iv) 3,125 shares of common stock issuable upon exercise of stock options to purchase shares of the Issuer's common stock with an exercise price of $104.00 per share, (v) 3,125 shares of common stock issuable upon exercise of stock options to purchase shares of the Issuer's common stock, with an exercise price of $44.80 per share and (vi) 750,000 shares of common stock issuable upon exercise of five-year warrants to purchase shares of the Issuer's common stock with an exercise price of $0.80 per share. The above number of shares amounts to approximately 28.6% of the 2,414,226 outstanding shares of common stock as of October 17, 2025.

**(b)**
The Reporting Person has the sole power to vote or to direct the vote, sole power to dispose or to direct the disposition of all shares beneficially owned by the Reporting Person.

**(c)**
Except as described in this Schedule 13D under Item 3 above, the Reporting Person did not engage in any transactions in shares of the Company's common stock during the past 60 days.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Not applicable.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Yorke Justin W

**Signature:** /s/ Yorke Justin W

**Name/Title:** Yorke Justin W, Individually

**Date:** 10/21/2025